4-Aminopyrazolo[3,4-d]pyrimidine: A Key Pharmaceutical Intermediate

Discover the critical role of 4-Aminopyrazolo[3,4-d]pyrimidine in advancing medicinal chemistry and cancer therapies.

Get a Quote & Sample

Key Advantages

High Purity Assurance

Benefit from the compound's assured high purity, often exceeding 98.0% via HPLC analysis, which is crucial for precise chemical synthesis and ensuring the quality of the final pharmaceutical product.

Critical Ibrutinib Component

As a primary intermediate for Ibrutinib, this chemical directly supports the production of a groundbreaking drug used in treating various B-cell cancers, highlighting its importance in the oncology drug pipeline.

Structural Versatility

Its adenine-like structure and heterocyclic organic molecule nature offer significant versatility, allowing it to act as an antimetabolite and be integrated into diverse complex molecular frameworks for medicinal chemistry research.

Key Applications

Ibrutinib Synthesis

This compound is indispensable for the synthesis of Ibrutinib, a significant pharmaceutical used to treat B-cell malignancies such as mantle cell lymphoma and chronic lymphocytic leukemia.

Cancer Drug Development

Its role as a key building block in cancer drug synthesis makes it a target for pharmaceutical companies focusing on targeted therapies and oncology research.

Medicinal Chemistry Research

Researchers utilize this heterocyclic organic molecule for its unique structural properties in exploring new drug candidates and understanding biochemical pathways.

Fine Chemical Manufacturing

As a high-purity intermediate, it is sought after by fine chemical manufacturers for various complex organic synthesis processes, ensuring quality and efficacy.